The clinical trial is expected to conclude by mid-2025, with top-line data anticipated by year-end 2024. The early results indicate the potential of LP-310 as a breakthrough treatment for OLP, a ...
However, the amount of excess melanin that can be produced is determined by genetics. Excessive melanin may also lead to skin diseases like melasma, Lichen planus pigmentosus or diffuse ...